Disability, Physical Inactivity, and Impaired Health-Related Quality of Life Are Not Different in Metabolically Healthy vs. Unhealthy Obese Subjects
Open accessThe DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
Background: Obesity represents a major health hazard, affecting morbidity, psychological status, physical functionality, quality of life, and mortality. The aim of the present study was to explore the differences between metabolically healthy (MHO) and metabolically unhealthy (MUO) obese subjects with regard to physical activity, disability, and health-related quality of life (HR-QoL). Methods: All subjects underwent a multidimensional evaluation, encompassing the assessment of body composition, metabolic biomarkers and inflammation, physical activity level (IPAQ questionnaire), disability (TSD-OC test), and HR-QoL (SF-36 questionnaire). MHO and MUO were defined based on the absence or the presence of the metabolic syndrome, respectively. Results: 253 subjects were included (54 men and 199 women; age: 51.7 ± 12.8 vs. 50.3 ± 11.7 years, p = 0.46; BMI: 38.1 ± 5.7 vs. 38.9 ± 6.7 kg/m2, p = 0.37). No significant difference was observed in body composition. There was no difference between MHO and MUO considering inflammation (hs-CRP: 6517.1 ± 11,409.9 vs. 5294.1 ± 5612.2 g/L; p = 0.37), physical inactivity (IPAQ score below 3000 METs-min/week in 77.6% of MHO vs. 80% of MUO subjects; p = 0.36), obesity-related disability (TSD-OC score > 33%, indicating a high level of obesity-related disability, in 20.2% of MHO vs. 26.5% of MUO subjects; p = 0.28), and the HR-QoL (SF-36 total score: 60 ± 20.8 vs. 62.8 ± 18.2, p = 0.27). Discussion and Conclusion: The metabolic comorbidity and the impairment of functional ability and psycho-social functioning may have a different timing in the natural history of obesity. Alterations in the physical activity level and mobility disabilities may precede the onset of metabolic abnormalities. (Trial registration 2369 prot 166/12—registered 23 February 2012; Amendment 223/14—registered 13 February 2014).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Skeletal muscle mass, estimated using techniques available for clinical practice such as BIA and DXA that do not directly assess muscle, is not a good indicator of functional impairment [104].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · cited 1×
“Metabolic syndrome: The definition proposed by the National Cholesterol Education Program—Third Adult Treatment Panel (NCEP-ATP III) was used, requiring at least three or more of the following criteria: triglycerides ≥150 mg/dL or use of lipid-lowering drugs, systolic blood pressure (BP) ≥130 mmHg, diastolic BP ≥85 mm…”
MethodThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“Insulin sensitivity was assessed as the insulin sensitivity index (ISI) calculated using the OGTT values as proposed by Matsuda and DeFronzo [11].”
MethodThe Whoqol Group (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00009-4 · Cited by 3,802
Anthropometric Standardization Reference Manual
Lohman, T. J., Roache, A. F., & Martorell, R. (1992) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199208000-00020 · Cited by 2,764 · cited 1×
“Obesity was defined as a BMI ≥ 30 kg/m2 [9].”
BackgroundWildman, R. P. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1617 · Cited by 1,618 · cited 1×
“In a large prospective study, the risks of all-cause and CVD mortality were 57% and 76% lower in MHO compared with metabolically unhealthy obese (MUO) subjects, respectively [2].”
ResultGrundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600
Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
Meigs, J. B., Wilson, P. W. F., Fox, C. S., Vasan, R. S., Nathan, D. M., Sullivan, L. M., & D’Agostino, R. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0594 · Cited by 1,062 · cited 1×
“Different longitudinal studies addressed this research question: two of them demonstrated an increased incidence of diabetes in MHO subjects after a follow-up of 11 and 20 years [27,28], while in another study (9-year follow-up), an increased risk for all-cause mortality was found in obese subjects regardless of their…”
BackgroundIdentification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049
Kramer, C. K., Zinman, B., & Retnakaran, R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-11-201312030-00008 · Cited by 961 · cited 1×
“Finally, even in the absence of metabolic abnormalities and compared with metabolically healthy normal-weight individuals, obese subjects are at increased risk for adverse long-term outcomes, supporting the concept that there is no healthy pattern of augmented weight and adiposity [12,29,30].”
BackgroundMetabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know?
Karelis, A. D., St-Pierre, D. H., Conus, F., Rabasa-Lhoret, R., & Poehlman, E. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0165 · Cited by 723
Kolotkin, R. L., Meter, K., & Williams, G. R. (2001) · Obesity Reviews · doi:10.1046/j.1467-789x.2001.00040.x · Cited by 700 · cited 1×
“Therefore, low levels of perceived QoL are consistent with deteriorated health status [46,47].”
BackgroundA proposed clinical staging system for obesity
Sharma, A. M., & Kushner, R. F. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.2 · Cited by 687 · cited 1×
“A multidimensional approach, considering the multifaceted clinical features of excess adiposity, could provide beneficial effects in terms of obesity care and obesity-related health risk management [48,49].”
BackgroundOrtega, F. B., Lee, D.-C., Katzmarzyk, P. T., Ruiz, J. R., Sui, X., Church, T. S., & Blair, S. N. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs174 · Cited by 468
Brochu, M., Tchernof, A., Dionne, I. J., Sites, C. K., Eltabbakh, G. H., Sims, E. A. H., & Poehlman, E. T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7365 · Cited by 443
Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements
Stern, S. E., Williams, K., Ferrannini, E., DeFronzo, R. A., Bogardus, C., & Stern, M. P. (2005) · Diabetes · doi:10.2337/diabetes.54.2.333 · Cited by 384
Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals
Calori, G., Lattuada, G., Piemonti, L., Garancini, M. P., Ragogna, F., Villa, M., Mannino, S., Crosignani, P., Bosi, E., Luzi, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-0665 · Cited by 346
Metabolically Healthy Obesity and Risk of Mortality
Hinnouho, G.-M., Czernichow, S., Dugravot, A., Batty, G. D., Kivimaki, M., & Singh-Manoux, A. (2013) · Diabetes Care · doi:10.2337/dc12-1654 · Cited by 317 · cited 3×
“showed that the prevalence of MHO subjects ranged from 9% to 41% [7], with prevalence estimates varying widely due to the definitions used and to the lack of consensus to describe metabolic health [24–26].”
BackgroundMethodRey‐López, J. P., de Rezende, L. F., Pastor‐Valero, M., & Tess, B. H. (2014) · Obesity Reviews · doi:10.1111/obr.12198 · Cited by 310 · cited 2×
“In a recent review of the literature, 30 definitions were identified in 27 different studies to describe metabolic health [22].”
BackgroundMethodThe Effect of Obesity on Disability vs Mortality in Older Americans
Al Snih, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.8.774 · Cited by 299 · cited 2×
“The majority of the studies analyzed the influence of obesity on mortality, while other aspects of health need to be considered [31].”
BackgroundAre Metabolically Normal but Obese Individuals at Lower Risk for All-Cause Mortality?
Kuk, J. L., & Ardern, C. I. (2009) · Diabetes Care · doi:10.2337/dc09-0574 · Cited by 286 · cited 2×
“Finally, even in the absence of metabolic abnormalities and compared with metabolically healthy normal-weight individuals, obese subjects are at increased risk for adverse long-term outcomes, supporting the concept that there is no healthy pattern of augmented weight and adiposity [12,29,30].”
BackgroundDoes Inflammation Determine Metabolic Health Status in Obese and Nonobese Adults?
Phillips, C. M., & Perry, I. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2038 · Cited by 278 · cited 1×
“Moreover, the use of other parameters like inflammatory status or insulin resistance does not seem to improve the efficacy of the definition of MHO to assess cardio-metabolic risk [7,23].”
BackgroundMetabolically healthy but obese individuals
Karelis, A. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61531-7 · Cited by 269
Metabolically healthy obesity: different prevalences using different criteria
Velho, S., Paccaud, F., Waeber, G., Vollenweider, P., & Marques-Vidal, P. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.114 · Cited by 249
Body mass index and mortality in nonsmoking older adults: the Cardiovascular Health Study.
Diehr, P., Bild, D. E., Harris, T. B., Duxbury, A., Siscovick, D., & Rossi, M. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.4.623 · Cited by 219 · cited 1×
“suggested that the desirable weight should be defined on the basis of alternative outcomes, such as disability or risk of disease [32].”
BackgroundRisk of disability and mortality due to overweight in a Finnish population.
Rissanen, A., Heliövaara, M., Knekt, P., Reunanen, A., Aromaa, A., & Maatela, J. (1990) · BMJ · doi:10.1136/bmj.301.6756.835 · Cited by 209
The Impact of Obesity on Active Life Expectancy in Older American Men and Women
Reynolds, S. L., Saito, Y., & Crimmins, E. M. (2005) · The Gerontologist · doi:10.1093/geront/45.4.438 · Cited by 193
Impact of BMI and the Metabolic Syndrome on the Risk of Diabetes in Middle-Aged Men
Ärnlöv, J., Sundström, J., Ingelsson, E., & Lind, L. (2011) · Diabetes Care · doi:10.2337/dc10-0955 · Cited by 175 · cited 1×
“Different longitudinal studies addressed this research question: two of them demonstrated an increased incidence of diabetes in MHO subjects after a follow-up of 11 and 20 years [27,28], while in another study (9-year follow-up), an increased risk for all-cause mortality was found in obese subjects regardless of their…”
BackgroundMortality and disability: the effect of overweight and obesity
Walter, S., Kunst, A. E., Mackenbach, J. P., Hofman, A., & Tiemeier, H. W. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.176 · Cited by 139 · cited 1×
“Finally, disabled people face a higher mortality risk than nondisabled people do regardless of the cause of disability [37,38].”
BackgroundKim, Y., Wilkens, L. R., Park, S.-Y., Goodman, M. T., Monroe, K. R., & Kolonel, L. N. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt108 · Cited by 133 · cited 1×
“, cancer, cardiovascular diseases, and diabetes) and mortality (premature, CVD-related, and all-cause mortality) [40,41].”
Mortality Risk Associated With Disability: A Population-Based Record Linkage Study
Majer, I. M., Nusselder, W. J., Mackenbach, J. P., Klijs, B., & van Baal, P. H. M. (2011) · American Journal of Public Health · doi:10.2105/ajph.2011.300361 · Cited by 117 · cited 1×
“Finally, disabled people face a higher mortality risk than nondisabled people do regardless of the cause of disability [37,38].”
BackgroundOpen questions about metabolically normal obesity
Pataky, Z., Bobbioni-Harsch, E., & Golay, A. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.235 · Cited by 105
Role of Fitness in the Metabolically Healthy but Obese Phenotype: A Review and Update
Ortega, F. B., Cadenas‐Sánchez, C., Sui, X., Blair, S. N., & Lavie, C. J. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.05.001 · Cited by 88
From Metabolic Normality to Cardiometabolic Risk Factors in Subjects With Obesity
Bobbioni‐Harsch, E., Pataky, Z., Makoundou, V., Laville, M., Disse, E., Anderwald, C. H., Konrad, T., Golay, A., & On Behalf of the RISC Investigators (2012) · Obesity · doi:10.1038/oby.2012.69 · Cited by 66 · cited 2×
“2% of subjects who were MHO at baseline developed one or more cardiometabolic risk factors after three years [29].”
BackgroundLower-Limb Joint Coordination Pattern in Obese Subjects
Ranavolo, A., Donini, L. M., Marí, S. M., Serrao, M., Silvetti, A., Iavicoli, S., Cava, E., Asprino, R., Pinto, A., & Draicchio, F. (2012) · BioMed Research International · doi:10.1155/2013/142323 · Cited by 48
Self-citationDonini, L. M., Cuzzolaro, M., Spera, G., Badiali, M., Basso, N., Bollea, M. R., Bosello, O., Brunani, A., Busetto, L., Cairella, G., et al. (2010) · PubMed · Cited by 45
Self-citationDonini, L. M., Brunani, A., Sirtori, A., Savina, C., Tempera, S., Cuzzolaro, M., Spera, G., Cimolin, V., Precilios, H., Raggi, A., et al. (2011) · Disability and Rehabilitation · doi:10.3109/09638288.2011.575529 · Cited by 43 · cited 2×
“A TSD-OC score, higher than 33%, is consistent with a high level of obesity-related disability [17].”
BackgroundSelf-citationDoes global obesity represent a global public health challenge?
Popkin, B. M. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.008458 · Cited by 40 · cited 1×
“int/gho/ncd/risk_ factors/obesity_text/en/) [1].”
Ostir, G. V., Markides, K. S., Freeman, D. H., & Goodwin, J. S. (2000) · PubMed · Cited by 40
Nondisease factors affected trajectories of disability in a prospective study.
Nusselder, W., Looman, C., & Mackenbach, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.09.009 · Cited by 39 · cited 2×
“The difference can be explained by diseases and other risk factors for those with mild disability, but it is plausible that more severe disabilities have an independent effect on mortality [39].”
BackgroundDalleck, L. C., Guilder, G. P. V., Richardson, T., Bredle, D. L., & Janot, J. M. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s67441 · Cited by 38
Gill, S. V., Walsh, M., Pratt, J. A., Toosizadeh, N., Najafi, B., & Travison, T. G. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.03.029 · Cited by 38
It is time to define metabolically obese but normal‐weight ( MONW ) individuals
López‐Miranda, J., & Pérez‐Martínez, P. (2013) · Clinical Endocrinology · doi:10.1111/cen.12181 · Cited by 34
Obesity and Sedentarism: Reviewing the Current Situation Within the WHO European Region
Middelbeek, L., & Breda, J. (2013) · Current Obesity Reports · doi:10.1007/s13679-013-0054-y · Cited by 33 · cited 1×
“, cancer, cardiovascular diseases, and diabetes) and mortality (premature, CVD-related, and all-cause mortality) [40,41].”
Health-related quality of life and body mass index among US adolescents
Cui, W., Zack, M. M., & Wethington, H. R. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0646-3 · Cited by 28 · cited 1×
“Therefore, low levels of perceived QoL are consistent with deteriorated health status [46,47].”
BackgroundArmour, B. S., Courtney‐Long, E. A., Campbell, V. A., & Wethington, H. R. (2012) · Preventing Chronic Disease · doi:10.5888/pcd9.120136 · Cited by 26
The impact of weight classification on safety: timing steps to adapt to external constraints.
Gill, S. V. (2015) · PubMed Central · Cited by 12
Research works printed but not linked: 2
- Mann, D.L., Zipes, D.P., Libby, P., Bonow, R.O., and Braunwald, E. (2015). Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, Elsevier Saunders. [10th ed.]. Chapter 39.
- Ostir, 2000, Obesity and health conditions in elderly Mexican Americans: The Hispanic EPESE, Ethn. Dis., 10, 31
Cited by
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Obesity Facts · doi:10.1159/000521241 · Cited by 1,019
Self-citationDefinition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.014 · Cited by 566
“Not only in sarcopenia, but also in obesity, functional impairment is very frequent and may occur well before old age [106–108].”
Self-citationDonini, L. M., Busetto, L., Bauer, J. M., Bischoff, S., Boirie, Y., Cederholm, T., Cruz-Jentoft, A. J., Dicker, D., Frühbeck, G., Giustina, A., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.024 · Cited by 326
“disability level) [105] that might be per se considered a surrogate for risk or presence of low muscle mass and-or function [106,107].”
BackgroundSelf-citationOrtega, F. B., Cadenas-Sanchez, C., Migueles, J. H., Labayen, I., Ruiz, J. R., Sui, X., Blair, S. N., Martínez-Vizcaino, V., & Lavie, C. J. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.07.008 · Cited by 137
Mota, M. C., Silva, C. M., Balieiro, L. C. T., Fahmy, W. M., & Crispim, C. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-06723-w · Cited by 117
Metadata
- Authors
- Donini, L., Merola, G., Poggiogalle, E., Lubrano, C., Gnessi, L., Mariani, S., Migliaccio, S., & Lenzi, A.
- Affiliations
- Sapienza University of Rome (IT)
- Foro Italico University of Rome (IT)
- Corresponding author
- Donini, Lorenzo
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2016-11-25
- Volume
- 8
- Issue
- 12
- Pages
- 759
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC5188414
- OpenAlex
- W2555783522
- Cited by
- 32
- References
- 49
- Citations by year
- 2024: 3 · 2023: 1 · 2022: 10 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 2 · 2017: 5
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- metabolically healthy obesity, metabolically unhealthy obesity, physical inactivity, health-related quality of life, metabolic syndrome, inflammation, C-reactive protein, body composition, physical activity, mobility impairment, functional capacity, psychosocial functioning, obesity-related comorbidities, body mass index, SF-36, International Physical Activity Questionnaire
- MeSH terms
- Adult, Female, Humans, Male, Middle Aged, Obesity, Quality of Life, Exercise, Metabolic Syndrome, Adiposity, Sedentary Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.